What Tamer Group does

Tamer Group is a Saudi family-owned integrated healthcare and wellness conglomerate founded in 1922 by Dr. Mohammed Said Tamer as the first pharmacy on the Arabian Peninsula in Jeddah. Over 100 years the group has grown to employ more than 4,000 people across pharmaceutical distribution, healthcare manufacturing, logistics, consumer goods and digital platforms, serving pharmacies, private and government hospitals, laboratories, polyclinics and consumer end-markets in Saudi Arabia, the wider GCC, Yemen, the Levant and MENA region.

The company operates four business sectors. In supply chain and distribution, Tamer Healthcare and Tamer Consumer market and distribute ethical branded pharmaceuticals, OTC products, generics, medical equipment, diagnostic machines, interventional cardiology, radiology, orthopedics, nutrition and personal care products to public and private sector buyers. In healthcare manufacturing, the group runs the SAJA joint venture (50-year partnership with Astellas and Daiichi-Sankyo) producing solid dosage forms in a 32,000 sq.m. facility, holds a majority stake in Arabio (the first vaccine production facility in the Middle East, supplying 10 vaccines on the Saudi mandatory immunization schedule and over 40% of the local vaccine market), and partners with Mölnlycke Healthcare to manufacture ProcedurePak custom surgical trays locally from 2024. The digital sector spans Mumzworld, the largest mother, baby and child e-commerce platform in the Middle East (2.5 million users across 20 countries, 250,000+ SKUs), Pharmaciaty (a B2C pharmacy e-commerce platform launched December 2022), VitaCare (a B2B procurement platform for pharmacies, polyclinics and hospitals) and the LumineticsCore AI diagnostic platform for diabetic retinopathy. The logistics sector, Tamer Logistics, offers third-party warehousing and fulfillment with nationwide 1-2 day delivery and is constructing a $200 million solar-powered logistics park in Riyadh scheduled to open in early 2026.

Tamer Group makes money primarily through transaction-based pharmaceutical and consumer goods distribution, third-party logistics managed services, licensing and manufacturing revenues from JVs (SAJA, Arabio, Tamer Mölnlycke Care), and marketplace or direct e-commerce sales through Mumzworld, Pharmaciaty and VitaCare. Pricing is quote-based and not publicly disclosed. The group holds strategic partnerships with PIF-owned Lifera and Sanofi (2023 MOU for localizing seven essential vaccines), Astellas, Daiichi-Sankyo, Mölnlycke and others, and is governed by an Oversight Board led by Chairman Ayman Tamer and Vice Chairman Faisal Tamer alongside independent advisors.

Name

Tamer Group

Legal name

Farouk and Maamoun Mohammed Said Tamer Industries Holding Company

Website

https://tamergroup.com

Company type

Private

Founded year

1922

Operating status

Operating

Headcount range

1,001–5,000 employees

Short description

Tamer Group is a 1922-founded, family-owned Saudi integrated healthcare and wellness conglomerate that distributes pharmaceuticals and consumer goods, manufactures vaccines and drugs via joint ventures, and operates e-commerce and logistics platforms across the MENA region.

Ownership category

akta.pro rank

Product category

Healthcare Distribution and Manufacturing

NAICS

Drugs and Druggists' Sundries Merchant Wholesalers (42421), Drugs and Druggists' Sundries Merchant Wholesalers (424210), Drugs and Druggists' Sundries Merchant Wholesalers (4242), General Warehousing and Storage (49311)

SIC

Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122), Wholesale-Medical, Dental & Hospital Equipment & Supplies (5047)

akta.pro primary industry

Vaccines & Cold-Chain Pharmaceutical Distributors (HLAIAJAG)

akta.pro secondary industries

Government & Public-Sector Pharmaceutical Supply (Tender/Prime Vendor) (HLAIAJAF), Third-Party Logistics (3PL) & Warehousing for Pharmaceuticals (HLAIAJAL), Vaccine Cold Chain, Storage & Distribution (HLAIAEAK), Vaccine & Public Health Immunization Cold Chain Logistics (TLAIAIAD), Pharmaceutical & Medical Device Packaging (GMP, Tamper-Evident, Cold-Chain Packs) (TLAIAGAI)

Keywords

• Pharmaceutical distribution
• Pharmaceutical manufacturing
• Healthcare logistics
• Consumer e-commerce
• Vaccine manufacturing

Headquarters

HQ city

Jeddah

HQ country

Saudi Arabia

HQ region

Middle East

Offices9 records

Markets served

GTM type

B2B and B2C

Offering type

Services

Cost components

Personnel, Supply Chain, Operations, Infrastructure, Technology or R&D, Marketing or Sales

Revenue model

1. Pharmaceutical Distribution: Distribution of pharmaceutical products including ethical branded products, OTC and generics to pharmacies, private and government hospitals, and other healthcare institutions. Tamer Group is the leading supplier of pharmaceutical products to the Saudi market.
2. Medical Equipment Distribution: Comprehensive solutions to hospitals and laboratories including diagnostic machines, reagents, interventional cardiology, radiology, and orthopedics products.
3. Healthcare Manufacturing: Licensing and manufacturing of pharmaceutical products through SAJA (JV with Astellas and Daiichi-Sankyo) and Arabio (vaccine production). Production includes therapeutics covering urology, cardiovascular, diabetes, oncology, specialty primary care, and nutraceuticals.
4. Digital/Nutrition Products: Importing and distributing nutrition and essential care products including baby food, nutritional products, toiletries, hair care, and skin and body care through B2C e-commerce platforms.
5. Logistics Services: Third-party logistics services providing distribution coverage through nationwide warehouses with geotargeted 1-2 day deliveries, scalable fulfillment services supporting business growth.
6. E-commerce Consumer Platforms: Revenue from consumer e-commerce platforms including Mumzworld (mother/baby/child products) and Pharmaciaty (pharmacy products) serving direct consumers.

Go-to-market motion2 records

Distribution channels6 records

Marketing channels7 records

Core offering

Tamer Group is an integrated Saudi healthcare and wellness company that imports, distributes, markets, and manufactures pharmaceutical products, medical equipment, vaccines, and consumer health/personal care goods. The company also operates third-party logistics services and digital e-commerce platforms (Mumzworld and Pharmaciaty) serving consumers and healthcare institutions across Saudi Arabia and the MENA region.

Product overview

Tamer Group is a Saudi integrated healthcare and wellness company founded in 1922, operating a multi-platform portfolio across healthcare distribution, pharmaceutical manufacturing, digital/e-commerce, and logistics. The core offerings include: Tamer Healthcare and Tamer Consumer for supply chain and distribution; SAJA and Arabio for pharmaceutical manufacturing; Mumzworld and Pharmaciaty for e-commerce; VitaCare for B2B pharmacy platforms; Tamer Logistics for third-party logistics; and LumineticsCore for AI-powered medical diagnostics. The company also operates SA'AID as its CSR arm. The diversified structure combines traditional healthcare distribution with digital transformation initiatives aligned to Saudi Vision 2030.

Differentiator

Problem solved

Functional benefit

Brands

• Mumzworld: Largest mother, baby and child e-commerce platform in the Middle East, serving families with local and international brands
• VitaCare
• Pharmaciaty
• SAJA Pharmaceutical
• Arabio
• Tamer Mölnlycke Care

Products and services

• Mumzworld The largest mother, baby and child e-commerce platform in the Middle East, serving families as a one-stop-shop for local and international brands across 20 countries.
• Pharmaciaty B2C e-commerce pharmacy platform serving consumers at home with pharmaceuticals and wellness products.
• VitaCare One-stop-shop B2B platform providing pharmacies, polyclinics, and hospitals with 24/7 access to pharmaceuticals, beauty, and wellness products with automated and digitized purchasing.
• LumineticsCore AI-powered computer vision platform that analyzes retinal images to detect diabetic retinopathy; FDA and Saudi FDA approved for clinical use.
• SAJA Pharmaceutical Pharmaceutical manufacturing joint venture with Astellas and Daiichi-Sankyo producing solid dosage forms (granulation, blending, tableting, encapsulation, coating, packaging) covering urology, cardiovascular, diabetes, oncology, specialty primary care, and nutraceuticals.
• Arabio (Arab Pharmaceutical Company) First vaccine production facility in the Middle East, manufacturing human vaccines and biopharmaceutical cold-chain products; supplies 10 vaccines that are part of the mandatory immunization schedule in Saudi Arabia.
• Tamer Mölnlycke Care Joint venture with Mölnlycke Healthcare AB (Sweden) manufacturing customized procedural trays (ProcedurePak) for the MENA region, offering 40-55% time savings in operating rooms.
• Tamer Logistics Third-party strategic logistics service provider with nationwide warehouses enabling 1-2 day deliveries across Saudi Arabia, offering scalable fulfillment services with expert management control over logistics operations.
• Tamer Healthcare Supply of pharmaceuticals, medical equipment, surgical products, diagnostic machines, reagents, interventional cardiology, radiology, and orthopedics products to hospitals and laboratories.
• Tamer Consumer Comprehensive consumer goods distribution covering marketing, selling, distribution and after-sales support for baby food, nutritional products, toiletries, hair care, and skin and body care products.

Quantifiable outcome

• Over 10% annual revenue growth for the last 10 years
• +4 more outcomes

Named customers7 records

Segments4 records

Ideal customer profiles4 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability3 records

Feature4 records

Partnerships

Nine partnerships are on record, tiered core and minor.

• LiferacoreStrategic or Co-development Partner · 6 July 2023Lifera, a biopharmaceutical company wholly owned by the Public Investment Fund (PIF), partnered with Sanofi and Arabio/Tamer Group to localize production of seven essential vaccines in Saudi Arabia. The partnership aims to strengthen local manufacturing of vaccines, increase access to world-class preventative medicines for Saudi citizens, and grow the local biopharmaceutical industry. Lifera serves as contract manufacturer to Sanofi through state-of-the-art manufacturing facilities.
• SanoficoreStrategic or Co-development Partner · 6 July 2023Sanofi, one of the world's leading pharmaceutical companies specializing in vaccine development, partnered with Lifera and Arabio to manufacture and supply vaccines in Saudi Arabia. Sanofi will share its biotechnological expertise and know-how to initially manufacture seven vaccines which are part of the mandatory immunization schedule. Sanofi has been a leader in vaccines for over 100 years, vaccinating over half a billion people worldwide annually including more than 10 million in the Gulf region.
• ArabiocoreStrategic or Co-development Partner · 6 July 2023Arab Pharmaceutical Company (Arabio) is majority owned by Tamer Group and is one of the first biopharmaceutical companies in the region, specialized in human vaccines and other biopharmaceutical cold chain products. Established in 2005 and headquartered in Riyadh with manufacturing facility in Makkah. Arabio is the market leader supplying 10 vaccines which are part of the mandatory vaccination schedule in Saudi Arabia. Tamer Group is the main shareholder in Arabio.
• FittyminorStrategic or Co-development Partner · 17 January 2023Tamer Group acquired Fitty, a sports membership app operating on a pay-per-use model. The app expanded rapidly to 600 affiliated gyms before acquisition, with plans for international expansion.
• MumzworldcoreStrategic or Co-development Partner · 1 January 2021Tamer Group acquired majority stake in Mumzworld in 2021, a Dubai-based e-commerce platform for mothers, babies and children. The platform reaches 2.5 million people in 20 countries and sells more than 250,000 products. Tamer Group had invested in Mumzworld more than ten years ago with the founders. The acquisition is part of Tamer Digital strategy and considered an innovation center for developing other e-Health platforms.
• Mölnlycke HealthcarecoreStrategic or Co-development PartnerJoint venture (Tamer Mölnlycke Care) between Mölnlycke Healthcare AB (Sweden) and Tamer Group to manufacture customized procedural trays (ProcedurePak®) locally in Saudi Arabia. Previously Tamer Group imported these trays; local production leads to quicker turnaround times. Custom procedure trays offer 40-55% time saving in operating rooms.
• AstellascoreStrategic or Co-development PartnerSAJA is a 50-year joint venture, licensing and supplying agreement with Astellas (along with Daiichi-Sankyo) producing the latest researched pharmaceutical products for Saudi, GCC, Yemen, and Levant markets. SAJA provides diversified products comprising novel generics and innovative technologies covering urology, cardiovascular, diabetes, oncology, specialty primary care and nutraceuticals.
• Daiichi-SankyocoreStrategic or Co-development PartnerSAJA is a 50-year joint venture with Daiichi-Sankyo (along with Astellas) licensing and supplying agreement producing the latest researched pharmaceutical products for Saudi, GCC, Yemen, and Levant markets. The SAJA pharmaceutical manufacturing facility is a 32,000 sq. m. site producing solid dosage forms.
• Khaled Juffali CompanycoreStrategic or Co-development PartnerKhaled Juffali Company is a co-shareholder in Arabio alongside Tamer Group. Arabio is almost fully owned by Saudi shareholders, with Tamer Group as majority shareholder and Khaled Juffali company as co-investor.

Scale indicators9 records

Recent moves7 records

Expansion highlights6 records

Direct peers

• Saudi Pharmaceutical Industries & Medical Appliances Corporation (SPIMACO): Leading Saudi pharmaceutical manufacturer and distributor; directly comparable to Tamer's SAJA and Tamer Healthcare operations in terms of product breadth, Saudi market focus, and government supply contracts.
• Tabuk Pharmaceuticals Manufacturing Company: Saudi-based pharmaceutical manufacturer with branded generics across cardiovascular, CNS, and antibiotics; comparable to Tamer's SAJA JV and Arabio in local manufacturing and Vision 2030 alignment.
• Julphar (Gulf Pharmaceutical Industries): MENA-based pharmaceutical manufacturer with regional distribution; comparable in scale, multi-country reach, and product categories (generics, OTC) to Tamer's pharma manufacturing and distribution business.
• Hikma Pharmaceuticals: Regional (Jordan-headquartered) generic pharma manufacturer with MENA and US operations; comparable business model to Tamer's SAJA JV in terms of branded generics, licensing partnerships, and diversified therapeutic categories.
• Nahdi Medical Company: Largest retail pharmacy chain in Saudi Arabia; comparable to Tamer's VitaCare and Pharmaciaty B2B/B2C pharmacy platforms and consumer care distribution in the Saudi healthcare consumer market.
• Avalon Pharma: Saudi-based pharmaceutical manufacturer focused on OTC, consumer health, and personal care products; comparable in scale, distribution model, and KSA consumer healthcare focus to Tamer Consumer and SAJA.

Broad incumbents

• Dr. Sulaiman Al Habib Medical Services Group (HMG): Saudi integrated private healthcare provider with hospitals, pharmacies, and digital services; comparable as a vertically integrated Saudi healthcare conglomerate pursuing adjacent digital and consumer plays similar to Tamer.
• Agility Logistics: Kuwait-headquartered global logistics provider with MENA warehousing and freight operations; comparable to Tamer Logistics as a regional 3PL operator with multi-country reach.
• Aramex: UAE-headquartered regional logistics and courier company; comparable to Tamer Logistics in MENA distribution and last-mile operations, though Aramex focuses more on parcels vs. pharma.

Emerging players

• Vezeeta: MENA digital health platform offering doctor booking, pharmacy, and tele-health; comparable to Tamer's Mumzworld, Pharmaciaty, and VitaCare platforms as a regional digital health commerce player.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks5 records

Key highlights7 records

Customer concentration

• Xtwitter.com/TamerHolding
• YouTubeyoutube.com/user/saaidcsr
• LinkedInlinkedin.com/company/tamer
• Instagraminstagram.com/tamerholding/?hl=en
• Facebookfacebook.com/tamergroupofficial

Compliance4 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles12 records

Subsidiaries10 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A2 records

Investments3 records

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Tamer Group